Who invested in Dxcover

One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$6.2Mraised across 1 round since 2025, from 1 source

Latest round: Venture, $6.2MFeb 2025
Investors: 4

See who backed them

The rounds

Feb 2025
Venture$6.2M
Source recorded

Funding filed with regulators

Dxcover filed 2 raises, $6.3M in all. Filings say how much was sold and to how many investors; they never name the investors.

Mar 2025$1.2MUK share allotment
Jan 2025$5.1MUK share allotment

Founders and team

From Dxcover's own website: 8 on the team.

Dr Holly J ButlerChief Technical Officer
John DuncanChief Financial Officer
Professor David S PalmerChief Scientific Officer
Professor Matthew J BakerChief Scientific Officer
Abigail LishmanHead Of Commercial Development (uk & Eu)
Dr Ewan GrayHead Of Health Economic & Outcomes Research
Dr David EustaceGeneral Manager
Ron A. AndrewsChair

Everyone who backed them

Innovate UKVC firm1round

Scottish EnterpriseGovernment1round

Maven Capital PartnersPrivate equity1round

British Business BankCorporate VC1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Dxcover as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.